# A Single Dose Study Of PF-06678552 In Healthy Subjects

> **NCT01992614** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06678552 or Placebo
- **DRUG:** PF-06678552 or Placebo
- **DRUG:** PF-06678552 or Placebo

## Key facts

- **NCT ID:** NCT01992614
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01992614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01992614, "A Single Dose Study Of PF-06678552 In Healthy Subjects". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01992614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*